Drug Target Review2025-07-01T14:41:16
AI is changing how clinical trials are run - quietly but significantly. Find out how digital twins are helping sponsors reduce control arms and accelerate development without changing trial endpoints.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., Drug Target Review
2024-01-19T07:40:55
Sponsored by Euretos
2026-07-01T06:30:00
Sponsored by BPS Bioscience, Dr Veronique Baron
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
2023-03-08T16:29:20
Sponsored by Bio-Techne
2026-05-22T07:38:00
Contributor Dr Helen Bright, Drug Target Review
Site powered by Webvision Cloud